Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer

Letrozole, an aromatase inhibitor (AI), is the first-line adjuvant drug for treating hormone receptor-positive (HR+) breast cancer in postmenopausal women. However, harmful adverse events (AEs) and significant differences in drug response among individuals remain a significant problem in clinical ap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Umamaheswaran, Gurusamy, Kadambari, Dharanipragada, Muthuvel, Suresh Kumar, Kumar, Naveena A. N., Dubashi, Biswajit, Aibor Dkhar, Steven, Adithan, Chandrasekaran
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990231/
https://ncbi.nlm.nih.gov/pubmed/33760860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247989
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars